ROIV

11.16

0.36% -0.04

Handel nachbörslich: 11.21 0.05 +0.45%

Roivant Sciences Ltd (ROIV)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt ROIV? Forum Prognose

Schlusskurs vom Vortag:

$11.20

Offen:

$11.18

24-Stunden-Volumen:

4.09M

Relative Volume:

0.69

Marktkapitalisierung:

$8.25B

Einnahmen:

$158.30M

Nettoeinkommen (Verlust:

$4.74B

KGV:

-8.3284

EPS:

-1.34

Netto-Cashflow:

$-710.11M

1W Leistung:

-5.50%

1M Leistung:

-6.38%

6M Leistung:

-0.62%

1J Leistung:

+24.41%

1-Tages-Spanne:

$11.04

$11.23

1-Wochen-Bereich:

$11.04

$12.05

52-Wochen-Spanne:

$8.56

$13.05

Roivant Sciences Ltd Stock (ROIV) Company Profile

Firmenname

Roivant Sciences Ltd

Sektor

Healthcare (1196)

Branche

Biotechnology (683)

Telefon

441-295-5950

Adresse

CLARENDON HOUSE, 2 CHURCH STREET, HAMILTON HM11

Mitarbeiter

908

Twitter

Nächster Verdiensttermin

2024-11-12

Neueste SEC-Einreichungen

ROIV's Discussions on Twitter

Vergleichen Sie ROIV mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
ROIV	11.16	8.25B	158.30M	4.74B	-710.11M	-1.34
VRTX	467.01	119.87B	10.63B	-479.80M	-1.35B	13.33
REGN	762.00	83.27B	13.85B	4.65B	3.32B	35.06
ARGX	567.90	33.96B	1.86B	-40.29M	-1.28B	-4.16
ALNY	232.27	30.18B	2.09B	-332.26M	16.06M	-4.14
BNTX	101.87	24.42B	3.30B	-501.07M	1.03B	11.54

Roivant Sciences Ltd Stock (ROIV) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-02-15	Eingeleitet	Wolfe Research	Outperform
2024-01-05	Eingeleitet	Piper Sandler	Overweight
2023-12-12	Eingeleitet	Deutsche Bank	Buy
2023-10-17	Eingeleitet	Guggenheim	Buy
2023-06-08	Eingeleitet	BofA Securities	Neutral
2022-10-27	Eingeleitet	JP Morgan	Overweight
2022-05-23	Eingeleitet	SVB Leerink	Outperform
2022-04-29	Eingeleitet	Cantor Fitzgerald	Overweight
2021-12-15	Eingeleitet	Goldman	Buy
2021-11-08	Eingeleitet	H.C. Wainwright	Buy
2021-10-28	Eingeleitet	Citigroup	Buy
2021-10-26	Eingeleitet	Cowen	Outperform
2021-10-26	Eingeleitet	Jefferies	Buy
2021-10-26	Eingeleitet	Truist	Buy

Alle ansehen

Roivant Sciences Ltd Aktie (ROIV) Neueste Nachrichten

Nov 15, 2024

Roivant Sciences Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024 - Marketscreener.com

Nov 14, 2024

Roivant Sciences Ltd. (NASDAQ:ROIV) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat

Nov 14, 2024

Trump’s appointment of Ramaswamy sparks speculation on Korean biotech firms linked to Roivant - KBR

Nov 14, 2024

Nov 13, 2024

Who is Vivek Ramaswamy? Know about his early life, education, and role as head of the new "Department of Government Efficiency" (DOGE) - MSN

Nov 13, 2024

From Vadakkanchery to top US Govt post: Vivek Ramaswamy's Kerala roots - Mathrubhumi English

Nov 13, 2024

The Analyst Landscape: 5 Takes On Roivant Sciences - Benzinga

Nov 13, 2024

How Vivek Ramaswamy Became A Billionaire - Forbes

Nov 13, 2024

Who is Vivek Ramaswamy? What to know about Cincinnati billionaire part of Trump's Cabinet - The Cincinnati Enquirer

Nov 13, 2024

Vivek Ramaswamy Net Worth 2024: How He Built a Billion-Dollar Empire - Black Star News

Nov 13, 2024

Vivek Ramaswamy's journey from bright son of immigrants to being Donald Trump's pick - The Economic Times

Nov 13, 2024

Roivant Sciences Ltd. (NASDAQ:ROIV) Q2 2024 Earnings Call Transcript - Insider Monkey

Nov 13, 2024

Vivek Ramaswamy Net Worth 2024: Salary, Net Worth in Rupees (INR), Annual Income, Houses, and Cars. - Jagran Josh

Nov 13, 2024

Who Is Vivek Ramaswamy, The Biotech Entrepreneur Now Part Of Trump 2.0 - NDTV

Nov 13, 2024

Vivek Ramaswamy Net Worth: How this key Trump aide built his billion-dollar empire - Moneycontrol

Nov 13, 2024